Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis
- PMID: 24719228
- DOI: 10.1007/s00296-014-3009-z
Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis
Abstract
Anti-neutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed to intracellular components of neutrophils and are present in several vasculitic syndromes. Recently, these autoantibodies have been described in other autoimmune disorders as well as in infectious diseases such as tuberculosis (TB). As there are some clinical similarities between TB and granulomatosis with polyangiitis, we searched for ANCA in a group of patients with proven TB. Patients with TB confirmed by chest X-ray and sputum bacilloscopy either before or within 30 days after beginning treatment were included in this study. Anti-MPO and anti-PR3 antibodies were studied using well-standardized ELISA kits (INOVA Diagnostics, Inc.). ANCA were also investigated by indirect immunofluorescence (IIF). Fifty TB patients (26 females, mean age 47.34 ± 17 years) were enrolled in the present study. No patient tested positive for ANCA by IIF, or anti-MPO or anti-PR3 antibodies by ELISA. Although previous studies have shown the presence of ANCA in some infectious diseases, the findings of the present study demonstrated the absence of such antibodies in TB. The discrepancy in the prevalence of ANCA in TB among different studies may be attributed to methodological factors and/or the genetic background of the studied populations.
Similar articles
-
Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):35-9. Clin Exp Rheumatol. 2010. PMID: 20412700
-
Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.Rheumatology (Oxford). 2005 Feb;44(2):247-50. doi: 10.1093/rheumatology/keh467. Epub 2004 Nov 16. Rheumatology (Oxford). 2005. PMID: 15546964
-
Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.Rheumatology (Oxford). 2003 Feb;42(2):223-9. doi: 10.1093/rheumatology/keg066. Rheumatology (Oxford). 2003. PMID: 12595614
-
Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.J Immunol Methods. 2018 Jul;458:1-7. doi: 10.1016/j.jim.2018.02.016. Epub 2018 Feb 24. J Immunol Methods. 2018. PMID: 29486145 Review.
-
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).Am J Clin Pathol. 1999 Apr;111(4):507-13. doi: 10.1093/ajcp/111.4.507. Am J Clin Pathol. 1999. PMID: 10191771 Review.
Cited by
-
Pulmonary granulomas in a patient with positive ANCA and history of tuberculosis: case report.BMC Pulm Med. 2020 Aug 14;20(1):219. doi: 10.1186/s12890-020-01258-9. BMC Pulm Med. 2020. PMID: 32795275 Free PMC article.
-
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis.Antibodies (Basel). 2019 May 1;8(2):31. doi: 10.3390/antib8020031. Antibodies (Basel). 2019. PMID: 31544837 Free PMC article. Review.
-
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis.Nat Commun. 2025 Feb 12;16(1):1582. doi: 10.1038/s41467-025-56786-x. Nat Commun. 2025. PMID: 39939347 Free PMC article.
-
Identification of autoimmune markers in pulmonary tuberculosis.Front Immunol. 2023 Jan 25;13:1059714. doi: 10.3389/fimmu.2022.1059714. eCollection 2022. Front Immunol. 2023. PMID: 36761174 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous